Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia
| Autor: | Luisa Ugedo, Asier Aristieta, José Vicente Lafuente, Elena Paredes-Rodriguez, Cristina Miguelez, Sergio Vegas-Suarez |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Levodopa
Parkinson's disease business.industry Dopaminergic Substantia nigra medicine.disease Abnormal involuntary movement nervous system diseases 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure nervous system Dyskinesia Dopamine medicine Neuron medicine.symptom business Neuroscience 030217 neurology & neurosurgery medicine.drug |
| DOI: | 10.1016/bs.irn.2019.06.013 |
| Popis: | Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra, the depletion of striatal dopamine and the presence of Lewy aggregates containing alpha-synuclein. Clinically, there are motor impairments involving cardinal movement symptoms, bradykinesia, resting tremor, muscle rigidity, and postural abnormalities, along with non-motor symptoms such as sleep, behavior and mood disorders. The current treatment for PD focuses on restoring dopaminergic neurotransmission by l -3,4-dihydroxyphenylalanine (levodopa), which loses therapeutic efficacy and induces disabling abnormal involuntary movements known as levodopa-induced dyskinesia (LID) after several years. Evidence indicates that the pathophysiology of both PD and LID disorders is also associated with the dysfunctional activity of the serotonergic (5-HT) neurons that may be responsible for motor and non-motor disturbances. The main population of 5-HT neurons is located in the dorsal raphe nuclei (DRN), which provides extensive innervation to almost the entire neuroaxis and controls multiple functions in the brain. The degeneration of DRN 5-HT neurons occurs in early PD. These neurons can also take exogenous levodopa to transform it into dopamine, which may disturb neuron activity. This review will provide an overview of the underlying mechanisms responsible for 5-HT dysfunction and its clinical relevance in PD and dyskinesia. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|